The GVN Robert C. Gallo Award for Scientific Excellence and Leadership
The GVN Robert C. Gallo Award for Scientific Excellence and Leadership awardees are nominated by their peers in recognition of their publication of important scientific information in the areas of virology of interest to the GVN, including but not limited to basic science, clinical aspects, pathogenesis, epidemiology, diagnostics, antivirals, and vaccine development. In addition, awardees have enacted GVN's mission—typically in several ways—such as by developing GVN's network of Centers of Excellence and Affiliates, participating in training programs, contributing to meetings and other GVN activities, and advocating for science-informed decision making and other public communication activities.
Robert F. Garry, PhD
Professor of Microbiology and Immunology
Assistant Dean for Biomedical Sciences
Tulane University School of Medicine
Sharon Lewin, FRACP, PhD, FAHMS
The Peter Doherty Institute for Infection and Immunity
William Hall, BSc, PhD, MD, DTMH
Michael Oldstone, MD
Professor, department of Immunology and Microbiology, California Campus.
Faculty member, Scripps Research Institute and Adjunct Professor at the Department of Neurosciences in UCSD School of Medicine.
Resident Scholar (Professor), at University of Alabama College of Arts and Sciences, Tuscaloosa, Alabama
Erica Ollmann Saphire, PhD
Professor of Immunology and Microbiology at The Scripps Research Institute
Diane Griffin, MD, PhD
Professor, Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health
Ab Osterhaus, DVM, PhD
Director of the University of Veterinary Medicine Hannover
Scott Weaver, MS, PhD
Chair of GVN’s Chikungunya and Zika Task Forces,
Director of the University of Texas Medical Branch’s Institute for Human Infections and Immunity, and Scientific Director of the Galveston National Laboratory
1. The candidate has published important scientific information in the areas of virology of interest to the GVN, including but not limited to: basic science, clinical aspects, pathogenesis, epidemiology, diagnostics, antivirals, and vaccine development.
2. The candidate has contributed with the implementation of the GVN mission, including but not limited to: development of the network of Centers of Excellence, participation in training programs, contribution to meetings and other GVN activities (such as Task Forces), and contribution to advocacy and public communication activities.
1. The Directors of GVN Centers of Excellence and Affiliates can nominate one or more scientists.
2. Nominations of women, young scientists, minorities and scientists from developing countries are encouraged, provided that they meet the selection criteria.
3. Nominations should be supported by a one-page summary describing how the candidate meets the selection criteria.
1. The GVN Scientific Advisory Committee will review the nominations to confirm that the information is complete and that the candidates meet the criteria.
2. Members of the Scientific Advisory Committee selects the honoree and prepare a short description justifying the selection.
Consists of a plaque. The honoree will be presented with the award at the Annual GVN Meeting and will be announced by the GVN.
Typically once a year.